FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Palisade Bio's Free Cash Flow for the
three
months ended in Mar. 2024 was $-3.18 Mil. Palisade Bio's Revenue for the
three
months ended in Mar. 2024 was $0.00 Mil. Therefore, Palisade Bio's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.
The historical rank and industry rank for Palisade Bio's FCF Margin % or its related term are showing as below:
PALI'
s FCF Margin % Range Over the Past 10 Years
Min: -4454.8 Med: -4454.8 Max: -4314.8
Current: -4314.8
During the past 4 years, the highest FCF Margin % of Palisade Bio was -4314.80%. The lowest was -4454.80%. And the median was -4454.80%.
PALI's FCF Margin % is ranked worse than 86.71% of 1046
companies
in the Biotechnology industry
Industry Median: -144.01
vs PALI: -4314.80
Palisade Bio FCF Margin % Historical Data
The historical data trend for Palisade Bio's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Palisade Bio's FCF Margin %
For the Biotechnology subindustry, Palisade Bio's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Palisade Bio's FCF Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Palisade Bio's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Palisade Bio's FCF Margin % falls into.
Palisade Bio FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
Palisade Bio's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Palisade Bio FCF Margin % Related Terms
Thank you for viewing the detailed overview of Palisade Bio's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PALI has been successfully added to your 